Navigating the Complexities of Disease Indication Selection for Treg Therapies
Time: 9:00 am
day: Conference Day Two
Details:
- Acknowledging the unique challenges faced by smaller biotech companies in making strategic decisions when selecting particular disease indications
- Discussing the implications of disease indication selection on the success of Treg therapies and how this may impact development decisions
- Offering strategic considerations and decision-making frameworks for smaller biotech’s to capitalize on market opportunity
